Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merli

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Infectious Diseases (London, England)|December 15, 2025
Empirical piperacillin/tazobactam vs carbapenems to treat bloodstream infections due to ESBL enterobacterales: a propensity score-matched observational study conducted in an emergency department in Northern ItalyNicolò Capsoni, Marco Bettina, Beatrice Bellone, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 18, 2025
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter StudyMassimo Iavarone, Eleonora Alimenti, Massimo Puoti, et al.
Microorganisms|April 26, 2025
Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection ControlFrancesco Peracchi, Giovanna Travi, Alice Proto, et al.
The Journal of Infection|October 31, 2020
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipientsMarco Merli, Luisa Pasulo, Giovanni Perricone, et al.
Transplantation|January 25, 2021
Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft RejectionMarco Merli, Claudia Alteri, Luna Colagrossi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2026
A randomized clinical trial to compare moxiFloxAcin veRsus aziTHromycin for the trEatment of MycoplaSma geniTalium: the FARTHEST StudyRoberto Rossotti, Chiara Baiguera, Davide Paolo Bernasconi, et al.
Plos One|September 1, 2023
Quantitative SARS-CoV-2 subgenomic RNA as a surrogate marker for viral infectivity: Comparison between culture isolation and direct sgRNA quantificationRossana Scutari, Silvia Renica, Valeria Cento, et al.
The Journal of Infection|July 12, 2020
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysisRoberto Rossotti, Giovanna Travi, Nicola Ughi, et al.
BMC Infectious Diseases|February 18, 2021
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept studyLuna Colagrossi, Maria Antonello, Silvia Renica, et al.
The New Microbiologica|October 3, 2022
The challenge of infectious diseases consultations in the emergency department: an Italian nationwide surveyNiccolò Riccardi, Roberta Maria Antonello, Andrea Giacomelli, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Infectious Diseases (London, England)|December 15, 2025
Empirical piperacillin/tazobactam vs carbapenems to treat bloodstream infections due to ESBL enterobacterales: a propensity score-matched observational study conducted in an emergency department in Northern ItalyNicolò Capsoni, Marco Bettina, Beatrice Bellone, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 18, 2025
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter StudyMassimo Iavarone, Eleonora Alimenti, Massimo Puoti, et al.
Microorganisms|April 26, 2025
Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection ControlFrancesco Peracchi, Giovanna Travi, Alice Proto, et al.
The Journal of Infection|October 31, 2020
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipientsMarco Merli, Luisa Pasulo, Giovanni Perricone, et al.
Transplantation|January 25, 2021
Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft RejectionMarco Merli, Claudia Alteri, Luna Colagrossi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2026
A randomized clinical trial to compare moxiFloxAcin veRsus aziTHromycin for the trEatment of MycoplaSma geniTalium: the FARTHEST StudyRoberto Rossotti, Chiara Baiguera, Davide Paolo Bernasconi, et al.
Plos One|September 1, 2023
Quantitative SARS-CoV-2 subgenomic RNA as a surrogate marker for viral infectivity: Comparison between culture isolation and direct sgRNA quantificationRossana Scutari, Silvia Renica, Valeria Cento, et al.
The Journal of Infection|July 12, 2020
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysisRoberto Rossotti, Giovanna Travi, Nicola Ughi, et al.
BMC Infectious Diseases|February 18, 2021
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept studyLuna Colagrossi, Maria Antonello, Silvia Renica, et al.
The New Microbiologica|October 3, 2022
The challenge of infectious diseases consultations in the emergency department: an Italian nationwide surveyNiccolò Riccardi, Roberta Maria Antonello, Andrea Giacomelli, et al.
Pageof 9